Hetty E. Carraway, MD, MBA, FACP, is a hematologist and medical oncologist with subspecialty expertise in leukemia, myeloid neoplasms, and bone marrow disorders. She serves as Director of the Leukemia Program and Vice Chair of Strategy and Enterprise Development at Cleveland Clinic’s Taussig Cancer Institute, where she is also a staff physician in the Department of Hematologic Oncology and Blood Disorders and Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Carraway’s clinical practice centers on leukemias, myeloid disorders, and bone marrow failure and related marrow disorders. Her research interests include experimental therapeutics and early-phase clinical trials, translational cancer biology and epigenetics, and genomic biomarkers of treatment response and resistance in hematologic malignancies. Her leadership roles include serving as Chair of the Committee on Training for the American Society of Hematology and previously as Program Director of the Hematology and Medical Oncology Fellowship Program at Cleveland Clinic Taussig Cancer Institute. She has been recognized with the Binaytara Distinguished Faculty of the Year Award. Dr. Carraway earned her medical degree from the University of Massachusetts Chan Medical School, completed her internal medicine residency at Johns Hopkins University School of Medicine, and went on to complete fellowship training in hematology and medical oncology at Johns Hopkins. She also earned an MBA from the Johns Hopkins Carey Business School.
Professor
Medical School
1993 – 1998
Residency
1998 – 2001
Fellowship
2001 – 2005